Cancer treatment has come a long way from a one-size-fits-all approach. Today, medicine is moving towards personalized therapy—treatments tailored to the unique genetic makeup of each patient’s cancer. One of the most powerful tools driving this shift is Next Generation Sequencing (NGS).
Gastrointestinal Stromal Tumour (GIST) is a rare type of cancer that forms in the digestive tract. Despite being uncommon, GIST is the most prevalent mesenchymal tumour of the gastrointestinal tract. Early detection,
Cancer remains one of the leading causes of mortality worldwide, yet not all cancers receive equal attention or have the same survival outcomes. Among these are the lesser-known and more deadly cancers collectively referred to as Less Survivable Cancers (LSCs). These include pancreatic, liver, lung, oesophageal, stomach, and brain cancers. Together, they account for a significant proportion of cancer-related deaths but often lack the public awareness necessary to improve outcomes.
Dr Arun Chandrasekharan‘s article about RMAC study: A randomized study for evaluation of metronomic adjuvant
Early detection of lung cancer: Advancements in lung cancer research have led to ongoing studies
Advances in Chemotherapy Cancer treatment: Immunotherapy and Targeted Therapy In the early 1900s, the famous
Cancer remains one of the leading causes of death worldwide—but
Cancer has always been viewed as a battle—one fought with surgery, chemotherapy, radiation, and advanced immunotherapies. These treatments share a common goal: destroy cancer cells before they destroy the body. But what if, instead of killing cancer cells, we could reprogram them back into healthy, normal cells?
Cancer treatment has come a long way from a one-size-fits-all approach. Today, medicine is moving towards personalized therapy—treatments tailored to the unique genetic makeup of each patient’s cancer. One of the most powerful tools driving this shift is Next Generation Sequencing (NGS).
